DigestRedComo funciona
Red
/
Empresas
Al
No verificado

Aldeyra Therapeutics, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaMedicina - VariosÓpticaSalud

28 Comunicados de prensa

Ver todos los comunicados de prensa
13/11/2025
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
Web y redes sociales
Telefonía
Industria
Aldeyra Therapeutics Announces Expansion of RASP Platform to Include Central Nervous System Diseases and Provides Updates on Reproxalap at Research & Development Webcast
Fuente
Aldeyra Therapeutics, Inc.
Editor
Business Wire
1.00
0
11/11/2025
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Web y redes sociales
Finanzas
Eventos
Industria
Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
Fuente
Aldeyra Therapeutics, Inc.
Editor
Business Wire
1.00
0
06/11/2025
Finanzas
Web y redes sociales
Oncología
Salud
Ciencia
Farmacéutica
Óptica
Biotecnología
Aldeyra Therapeutics to Host Research & Development Update Webcast Event Scheduled for Thursday, November 13 at 8:00 a.m. ET
Fuente
Aldeyra Therapeutics, Inc.
Editor
Business Wire
1.00
0
28/10/2025
Multimedia
Industria
Ciencia
Biotecnología
Farmacéutica
Óptica
Salud
Medicina - Varios
Aldeyra Therapeutics Announces Positive Results from Phase 2 Clinical Trial in Alcohol-Associated Hepatitis, Focuses RASP Product Candidate Pipeline on Next-Generation Molecules
Fuente
Aldeyra Therapeutics, Inc.
Editor
Business Wire
1.00
0
03/09/2025
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Higiene alimentaria
Medicina - Varios
Web y redes sociales
Eventos
Industria
Aldeyra Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Fuente
Aldeyra Therapeutics, Inc.
Editor
Business Wire
1.00
0
28/08/2025
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Higiene alimentaria
Medicina - Varios
Industria
Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Primary Large B-Cell Lymphomas of Immune-Privileged Sites, including Primary Vitreoretinal Lymphoma
Fuente
Aldeyra Therapeutics, Inc.
Editor
Business Wire
1.00
0
19/08/2025
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Óptica
Industria
Aldeyra Therapeutics Receives Fast Track Designation for ADX‑2191 for the Treatment of Retinitis Pigmentosa
Fuente
Aldeyra Therapeutics, Inc.
Editor
Business Wire
1.00
0
06/08/2025
Biotecnología
Farmacéutica
Óptica
Salud
Eventos
Web y redes sociales
Aldeyra Therapeutics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
Fuente
Aldeyra Therapeutics, Inc.
Editor
Business Wire
1.00
0
24/07/2025
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Industria
Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Inherited Retinal Dystrophies including Retinitis Pigmentosa
Fuente
Aldeyra Therapeutics, Inc.
Editor
Business Wire
1.00
0
17/07/2025
Ciencia
Biotecnología
Farmacéutica
Óptica
Salud
Higiene alimentaria
Medicina - Varios
Industria
Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease
Fuente
Aldeyra Therapeutics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0